Literature DB >> 15675606

Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.

Jesús Pintor1.   

Abstract

The potential utility of naturally occurring nucleotide compounds in the treatment of ocular hypertension and glaucoma is described. Nucleotides are compounds that can modify the hydrodynamics of the aqueous humor by modulating the activity of nerve terminals that control the drainage and production of aqueous humor in the eye. Their mechanisms of action are focused on reducing intraocular pressure, thereby preventing optic nerve damage. These agents are candidates for the treatment of ocular hypertension and glaucoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15675606

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  2 in total

1.  2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.

Authors:  Shay Eliahu; Alba Martín-Gil; María Jesús Perez de Lara; Jesús Pintor; Jean Camden; Gary A Weisman; Joanna Lecka; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

2.  A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.

Authors:  Tali Fishman Jacob; Vijay Singh; Mudit Dixit; Tamar Ginsburg-Shmuel; Begoña Fonseca; Jesus Pintor; Moussa B H Youdim; Dan T Major; Orly Weinreb; Bilha Fischer
Journal:  Purinergic Signal       Date:  2018-07-17       Impact factor: 3.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.